Compile Data Set for Download or QSAR
Report error Found 79 Enz. Inhib. hit(s) with all data for entry = 11490
TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620523(2-((Bis(3-borono-5-(trifluoromethyl)phenyl)(oxo)-&...)
Affinity DataKd:  6.00E+4nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620519((S)-2,3-Bis(1-hydroxy-4-(trifluoromethyl)-1,3-dihy...)
Affinity DataKd:  2.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620521((3-Borono-5-((3-borono-5-(pentafluoro-λ6-sulf...)
Affinity DataKd:  3.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620507(3-Borono-5-(5-borono-2,4-difluorobenzoyl)benzoic a...)
Affinity DataKd:  3.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620512((3-Borono-5-((3-borono-5-(trifluoromethyl)phenyl)d...)
Affinity DataKd:  4.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620509((S)-2,3-Bis(7-fluoro-1-hydroxy-1,3-dihydrobenzo[c]...)
Affinity DataKd:  5.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620528(2-((Bis(3-borono-5-chlorophenyl)(oxo)-λ6-sulf...)
Affinity DataKd:  6.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620536(4-Borono-2-((3-borono-5-(trifluoromethyl)phenyl)su...)
Affinity DataKd:  7.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620537(2-((Bis(3-borono-5-(trifluoromethoxy)phenyl)(oxo)-...)
Affinity DataKd:  8.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620524(N-(4-(Difluoromethyl)-1-hydroxy-1,3-dihydrobenzo[c...)
Affinity DataKd:  8.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620499(N-(7-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  8.00E+5nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620506(3-Borono-5-(3-borono-5-fluorobenzoyl)benzoic acid ...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620520(4-((3S,4S)-3,4-Bis(1-hydroxy-4-(trifluoromethyl)-1...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620500(3,5-Bis((7-fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620535(N-(1-Hydroxy-4-((trifluoromethyl)sulfonyl)-1,3-dih...)
Affinity DataKd:  1.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620517((3-Borono-5-((3-borono-5-fluorophenyl)sulfonyl)ben...)
Affinity DataKd:  1.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620518(N-(1-Hydroxy-4-(trifluoromethyl)-1,3-dihydrobenzo[...)
Affinity DataKd:  1.30E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620534(N-(1-Hydroxy-4-(methylsulfonyl)-1,3-dihydrobenzo[c...)
Affinity DataKd:  1.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620513((3-Borono-5-(3-borono-5-(trifluoromethyl)benzoyl)b...)
Affinity DataKd:  1.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620501(N-(5-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  1.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620511((S)-2,3-Bis(4-fluoro-1-hydroxy-1,3-dihydrobenzo[c]...)
Affinity DataKd:  1.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620514((3-Borono-5-((3-borono-5-(trifluoromethyl)phenyl)s...)
Affinity DataKd:  1.70E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620505(3-Borono-5-((3-borono-4-fluorophenyl)sulfonyl)-4-f...)
Affinity DataKd:  1.80E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620533((S)-2,3-Bis(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  2.00E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620516((3-Borono-5-(3-borono-5-fluorobenzoyl)benzoyl)glyc...)
Affinity DataKd:  2.00E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620527(2-((Bis(3-borono-5-(difluoromethyl)phenyl)(oxo)-&#...)
Affinity DataKd:  2.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620522(4-[(3R,4R)-3,4-bis[[1-hydroxy-4-(trifluoromethyl)-...)
Affinity DataKd:  2.30E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620529(2-((Bis(3-boronophenyl)(oxo)-λ6-sulfanylidene...)
Affinity DataKd:  2.30E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620532((3-Borono-5-((3-boronophenyl)sulfonyl)benzoyl)glyc...)
Affinity DataKd:  2.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620503(N-(6-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  2.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620498((S)-2,4-bis(4-borono-3-fluorobenzamido)butanoic ac...)
Affinity DataKd:  2.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620515(4-((3S,4S)-3,4-Bis(7-fluoro-1-hydroxy-1,3-dihydrob...)
Affinity DataKd:  2.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620497(N,N′-bis(4-borono-3-fluorobenzamido)-N-ethyl...)
Affinity DataKd:  2.70E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620502(N-(4-Fluoro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  2.70E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620495(3,5-Bis((4-borono-2-fluorobenzamido)methyl)benzoic...)
Affinity DataKd:  3.10E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620504(N2,N6-Bis(6-fluoro-1-hydroxy-1,3-dihydrobenzo[c][1...)
Affinity DataKd:  3.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620525(N-(4-Chloro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxab...)
Affinity DataKd:  3.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620508(N6-(4-Borono-2-fluorobenzoyl)-N2-(6-fluoro-1-hydro...)
Affinity DataKd:  3.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620496(3,5-Bis((4-borono-3-fluorobenzamido)methyl)benzoic...)
Affinity DataKd:  3.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620531(2-((Bis(1-hydroxy-4-(trifluoromethyl)-1,3-dihydrob...)
Affinity DataKd:  3.70E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620507(3-Borono-5-(5-borono-2,4-difluorobenzoyl)benzoic a...)
Affinity DataKd:  4.00E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620530(N-(1-Hydroxy-5-(trifluoromethyl)-1,3-dihydrobenzo[...)
Affinity DataKd:  4.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620510((S)-2,3-Bis(5-fluoro-1-hydroxy-1,3-dihydrobenzo[c]...)
Affinity DataKd:  4.20E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620534(N-(1-Hydroxy-4-(methylsulfonyl)-1,3-dihydrobenzo[c...)
Affinity DataKd:  4.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620526((S)-3-(2,3-Bis(4-chloro-1-hydroxy-1,3-dihydrobenzo...)
Affinity DataKd:  4.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620496(3,5-Bis((4-borono-3-fluorobenzamido)methyl)benzoic...)
Affinity DataKd:  5.40E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620498((S)-2,4-bis(4-borono-3-fluorobenzamido)butanoic ac...)
Affinity DataKd:  6.50E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620495(3,5-Bis((4-borono-2-fluorobenzamido)methyl)benzoic...)
Affinity DataKd:  8.60E+6nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620519((S)-2,3-Bis(1-hydroxy-4-(trifluoromethyl)-1,3-dihy...)
Affinity DataKd:  1.00E+7nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

TargetGlucagon-like peptide 1 receptor(Human)
Novo Nordisk

US Patent
LigandPNGBDBM620509((S)-2,3-Bis(7-fluoro-1-hydroxy-1,3-dihydrobenzo[c]...)
Affinity DataKd:  1.00E+7nMAssay Description:The alizarin-red binding assay is a colorimetric assay used to determine the inhibition affinity of boronate compounds to glucose. The assay is based...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2023
Entry Details
US Patent

Displayed 1 to 50 (of 79 total ) | Next | Last >>
Jump to: